A child with resistant Kawasaki disease successfully treated with anakinra: a case report
Abstract Background Kawasaki disease (KD) is an acute self-limited systemic vasculitis of unknown etiology. Intravenous immunoglobulin (IVIG) is an effective treatment and decreases the risk of cardiac complications to less than 5%. In spite of its effectiveness, some children do not respond to this...
Saved in:
Main Authors: | J. Sánchez-Manubens (Author), A. Gelman (Author), N. Franch (Author), S. Teodoro (Author), J. R. Palacios (Author), N. Rudi (Author), J. Rivera (Author), J. Antón (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
by: Alessandro Gambacorta, et al.
Published: (2020) -
Continuous IV infusion of anakinra
by: Brittney N. Saunders, et al.
Published: (2023) -
Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab
by: Angel Luis Salcedo-Mingoarranz, et al.
Published: (2023) -
Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
by: Grazia Bossi, et al.
Published: (2022) -
Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
by: Anton J, et al.
Published: (2011)